Indian Drug Makers See More Bulk Products From China
This article was originally published in PharmAsia News
Indian drug makers complain Chinese companies plan to flood the Indian market with cheaper pharmaceuticals and medical devices, in some cases at half-price. Chinese firms have been blamed in India already for flooding the market with cheaper bulk drugs, but now they are seen entering other parts of the bulk supply market. The products headed for India range from traditional medicines to pharmaceuticals to medical instruments. Major producers of branded drugs in India are not expected to be hit as hard by the new competition as small-scale businesses. (Click here for more
You may also be interested in...
Designed to decrease venous leak from the corpora cavernosa, Giddy makes its Eddie device in oblong shape that opens at one point into two S-forms. Elastic bands are placed around the S-forms to pull the shape together at variable tensions.
Veklury is now the first US FDA-approved treatment for COVID-19, but its limited benefits means its lifespan as a blockbuster could be short.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.